Literature DB >> 8845179

Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.

B Galve-de Rochemonteix1, L P Nicod, J M Dayer.   

Abstract

Tumor necrosis factor alpha(TNF alpha), a proinflammatory cytokine secreted predominantly by monocytemacrophages, interacts with two cell-surface receptors: TNF-R55 and TNF-R75. Few studies have been devoted to their modulation on human alveolar macrophages (AM). Both source and target of TNF(alpha), AM also release its inhibitors, the soluble receptors, following the cleavage of the extracellular domain of TNF-R55 and TNF-R75. Because in vivo AM are subject to activation by exogenous or endogenous stimuli, we analyzed the release of both receptors into the cell culture supernatant in response to lipopolysaccharide (LPS), phorbol myristate acetate (PMA), and cytokines such as interleukin 2(IL-2), IL-4, IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF), and interferon gamma (IFN-gamma). Results were compared with those obtained on peripheral blood monocytes (Mo), and the role of receptor recycling was investigated using inhibitors such as monensin and chloroquine. In our culture conditions, basal release by unstimulated AM amounted to 0.3 +/- 0.1 and 0.5 +/- 0.1 ng/ml for TNF-sR55 and TNF-sR75, respectively. In the same conditions, Mo released 1.2 +/- 1.2 ng/ml of TNF-sR55 and 5.1 +/- 0.1 ng/ml of TNF-sR75. PMA slightly increased mRNA expression and release of TNF-sR55, but those of TNF-sR75 were enhanced approximately 4-fold. After 24 h of culture, the release of TNF-sR75 was 2.5-fold higher on Mo than on AM. Of the cytokines tested on AM, IFN-gamma increased the release of TNF-sR75 3-fold, but that of TNF-sR55 only between 1.5- and 2-fold. GM-CSF enhanced them to a lower extent (approximately 1.5-fold). Shedding occurred despite the presence of chloroquine, monensin and colchicine, suggesting that cleavage takes place on the cell surface rather than after internalization. Addition of colchicine increased the release of TNF-sR75 induced by LPS and IFN-gamma, but not by PMA. In conclusion, Mo and AM differ in their ability to release TNF(alpha) and TNF-sR. On AM the release of each receptor appears to be regulated separately. Finally, IFN-gamma was among the most efficacious cytokines to induce the release of both receptors, with TNF-sR75 being more liable to shedding. Thus, the two TNF-R seem to be ruled by separate mechanisms and to differ in terms of release sensitivity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8845179     DOI: 10.1165/ajrcmb.14.3.8845179

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  7 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Reduced production of interleukin 12 by interferon gamma primed alveolar macrophages from atopic asthmatic subjects.

Authors:  M J Plummeridge; L Armstrong; M A Birchall; A B Millar
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

3.  Mathematical model of sarcoidosis.

Authors:  Wenrui Hao; Elliott D Crouser; Avner Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-27       Impact factor: 11.205

4.  Inter-relationship between tumour necrosis factor-alpha (TNF-alpha) and TNF soluble receptors in pulmonary sarcoidosis.

Authors:  L Armstrong; N M Foley; A B Millar
Journal:  Thorax       Date:  1999-06       Impact factor: 9.139

5.  Beneficial or deleterious effects of a preexisting hypersensitivity to bacterial components on the course and outcome of infection.

Authors:  Marina Gumenscheimer; Ivan Mitov; Chris Galanos; Marina A Freudenberg
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

6.  Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.

Authors:  John R Glossop; Peter T Dawes; Nicola B Nixon; Derek L Mattey
Journal:  Arthritis Res Ther       Date:  2005-09-07       Impact factor: 5.156

Review 7.  TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages.

Authors:  Harald Wajant; Daniela Siegmund
Journal:  Front Cell Dev Biol       Date:  2019-05-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.